Immunotherapy Treatment

Immunotherapy Treatment

Immunotherapy is a radical form of cancer treatment and its principle consists in strengthening the immune system of the body or it is done to modify the immune system to detect and kill cancerous cells. Immunotherapy is a kind of therapy that is not similar to chemotherapy or in targeted therapy as it is not a therapy that kills the tumor cells directly. It, rather, assists the immune system to respond more effectively to the disease.

Immunotherapy in the Indian Cancer Treatment Centre is only provided after clinical and diagnostic assessment. The treatment is prescribed in case of medical indication that is evident and underpinned by scientific facts and developed clinical guidelines.

What Is Immunotherapy?

The immune system is delegated the power to identify and eliminate the cancerous cells. However, there are instances when the immune system can ignore the cancer cells. This challenge can be overcome through immunotherapy by:

  • Stimulating the immune cells to identify and kill cancer.

  • Elimination of the biological barriers to inhibit immune response.

  • Stimulating the immune response against tumor cells.

Immunotherapy is not applicable to all cancers and patients. Its application varies based on the biology of the tumors, stage of illness, presence of biomarkers and generally on the general health of a patient.

Types of Immunotherapy Used in Cancer Care

Based on clinical indication, immunotherapy may include:

  • Immune checkpoint inhibitors

  • Monoclonal antibodies

  • Immune modulating agents

The choice of treatment is guided by diagnostic findings, biomarker analysis, and evidence based oncology protocols.

Cancers Commonly Treated with Immunotherapy

Immunotherapy is used in selected cases of:

  • Lung cancer

  • Melanoma

  • Head and neck cancers

  • Kidney cancer

  • Certain gastrointestinal cancers

  • Some hematological malignancies

Eligibility depends on tumor biology, specific biomarkers, and alignment with current clinical guidelines.

Immunotherapy Approach at ICTC

Comprehensive Diagnostic Evaluation

Patients are assessed through structured assessment before the immunotherapy starts and include:

  • Histopathological diagnosis.

  • Appropriate biomarker and molecular testing where necessary.

  • Risk factor and comorbidity evaluation using immune related risk factors.

This makes sure that there is accuracy in decision making on treatment and that it is medically suitable.

Individualized Treatment Planning

Every immunotherapy treatment is grounded on:

  • Cancer type and stage

  • Biomarker status

  • Overall health of the patient and his/her comorbidities.

The idea is to get the maximum benefit whilst keeping the patients safe.

Multidisciplinary Oversight

ICTC implements a multidisciplinary oncology care system to provide immunotherapy services, consisting of medical oncologists, pathologists, imaging specialists, and supportive care professionals. This team work is beneficial to:

  • Appropriate patient selection

  • Safe therapy administration

  • Early identification and management of immune related side effects

How Immunotherapy Is Given

Immunotherapy is most commonly administered as:

Intravenous infusions at scheduled intervals

It can be used with chemotherapy or targeted therapy in some instances in the event of clinical description.

The duration and the schedule of treatment depend on the type of cancer, the response to treatment, and the tolerance of the patient.

Side Effects and Monitoring

The side effects of immunotherapy differ with those of chemotherapy. Due to its immune system stimulating effects, certain side effects can be immune in nature and they can include:

  • Skin reactions

  • Fatigue

  • Inflammation of organs such as thyroid, lungs, or intestines

In ICTC, the patients undergo frequent clinical assessment and lab tests. Early detection is a timely management and this assists in minimizing the risk of complications and continuity of care.

Patient Journey at ICTC

1. Specialist Consultation

Comprehensive clinical assessment and debate on diagnosis and possible treatment procedures.
↓

2. Diagnostic and Biomarker Testing

Diagnosis of suitability by pathology and biomarker examination.
↓

3. Treatment Planning

Clinical evidence to choose a proper immunotherapy protocol.
↓

4. Therapy Administration

Controlled clinical environment supervised infusion based treatment.
↓

5. Ongoing Monitoring

Review of response regularly and close monitoring of side effects.

In this journey, patient communication, safety and ethical transparency are among the core aspects of care delivery.

Why Choose ICTC for Immunotherapy?

  • Selecting patients based on evidence.

  • Availability of high level diagnostic and biomarker tests.

  • Accomplished oncology experts.

  • Combined chemotherapy, targeted therapy and supportive care services.

  • Good and transparent treatment choices.

ICTC immunotherapy is provided with planned assessment, close observation and multidisciplinary expertise.